COVID-19 Vaccine Effectiveness Among Older Adults in 2025/26
COVID-19, SARS-CoV-2, Vaccine effectiveness, Europe
Respiratory Syncytial Virus (RSV), Nirsevimab, Infant immunisation, Immunisation impact, Number needed to immunise (NNI)